AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35698288 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Surveillance
Number of subjects: 0
Study 35698288 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35698581 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks for 52 weeks
Number of subjects: 193
Study 35698581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193
Study 35698787 — intervention group
Group type: EXPERIMENTAL
Intervention: Wilcoxon-Mann-Whitney test
Number of subjects: 0
Study 35698787 — intervention group
Group type: EXPERIMENTAL
Intervention: Brunner-Munzel test
Number of subjects: 0
Study 35698787 — intervention group
Group type: EXPERIMENTAL
Intervention: Test procedure based on the log win odds
Number of subjects: 0
Study 35698787 — intervention group
Group type: EXPERIMENTAL
Intervention: Modification of the win ratio
Number of subjects: 0
Study 35698787 — intervention group
Group type: EXPERIMENTAL
Intervention: FREEDOMS clinical trial methodology
Number of subjects: 0
Study 35698835 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1-BNT162b2 (AZ-Pf group)
Number of subjects: 31
Study 35698835 — intervention group
Group type: COMPARATOR
Intervention: ChAdOx1 (AZ-AZ group)
Number of subjects: 31
Study 35698886 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical Vestibular Evoked Myogenic Potentials with bone-conduction as a vestibular screening tool
Number of subjects: 254
Study 35698971 — intervention group
Group type: EXPERIMENTAL
Intervention: Early venous filling (EVF) evaluated by 2 blinded readers
Number of subjects: 909
Study 35698971 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-Alberta Stroke Program Early CT-Glycemia-EVF score
Number of subjects: 909
Study 35699077 — intervention group
Group type: EXPERIMENTAL
Intervention: VSV-GP (BI 1831169)
Number of subjects: 0
Study 35699077 — intervention group
Group type: EXPERIMENTAL
Intervention: VSV-GP (BI 1831169) combined with ezabenlimab (BI 754091)
Number of subjects: 0
Study 35699183 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical closure of atrial septal defect (n=33)
Number of subjects: 62
Study 35699183 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical closure of ventricular septal defect (n=29)
Number of subjects: 62
Study 35699183 — intervention group
Group type: COMPARATOR
Intervention: Healthy matched controls (n=38)
Number of subjects: 62
Study 35699443 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochleated Amphotericin B (CAMB)
Number of subjects: 0
Study 35699443 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35699482 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ambulatory cardiac monitoring (rACM) for 2 weeks pre- and post-TAVI
Number of subjects: 192
Study 35699482 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ambulatory cardiac monitoring (rACM)
Number of subjects: 192
Study 35699578 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based cardiac MRI measurements
Number of subjects: 539
Study 35699910 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin (SGLT2 inhibitor)
Number of subjects: 0
Study 35699910 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35699949 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 1 diabetes mellitus (T1DM) participants
Number of subjects: 416
Study 35699949 — intervention group
Group type: COMPARATOR
Intervention: Control subjects without diabetes
Number of subjects: 416
Study 35699976 — intervention group
Group type: EXPERIMENTAL
Intervention: High agency (perceived control over the outcome)
Number of subjects: 178
Study 35699976 — intervention group
Group type: COMPARATOR
Intervention: Low agency (no control over the outcome)
Number of subjects: 178
Study 35699976 — intervention group
Group type: EXPERIMENTAL
Intervention: High immediacy (short-term negative health outcome)
Number of subjects: 178
Study 35699976 — intervention group
Group type: EXPERIMENTAL
Intervention: Low immediacy (long-term negative health outcome)
Number of subjects: 178
Study 35699977 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-patient digital research platform (Eureka Research Platform) for onboarding, consent, and activities in the digital study.
Number of subjects: 907
Study 35700000 — intervention group
Group type: EXPERIMENTAL
Intervention: Preprocedural immersive virtual reality (IVR) game preparation (IMAGINE)
Number of subjects: 98
Study 35700000 — intervention group
Group type: COMPARATOR
Intervention: Usual care (standard care as per the radiology department's protocol)
Number of subjects: 98
Study 35700019 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week physical activity program
Number of subjects: 110
Study 35700019 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110
Study 35700023 — intervention group
Group type: EXPERIMENTAL
Intervention: Health promotion program promoting HPV vaccination (information to students and parents, training of general practitioners, free school-based vaccination)
Number of subjects: 504
Study 35700023 — intervention group
Group type: COMPARATOR
Intervention: Control group (students from another middle school who will not attend the program)
Number of subjects: 504
Study 35700020 — intervention group
Group type: EXPERIMENTAL
Intervention: NiteCAPP CARES (web-based cognitive behavioral therapy for insomnia)
Number of subjects: 100
Study 35700020 — intervention group
Group type: COMPARATOR
Intervention: NiteCAPP SHARES (web-based sleep hygiene control)
Number of subjects: 100
Study 35700026 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural D1D (R-D1D) program, a culturally adapted virtual DSMES program for rural populations.
Number of subjects: 64
Study 35700026 — intervention group
Group type: COMPARATOR
Intervention: Standard patient education (control group).
Number of subjects: 64
Study 35700142 — intervention group
Group type: EXPERIMENTAL
Intervention: Finerenone 10 mg or 20 mg plus empagliflozin 10 mg
Number of subjects: 807
Study 35700142 — intervention group
Group type: COMPARATOR
Intervention: Empagliflozin 10 mg alone
Number of subjects: 807
Study 35700142 — intervention group
Group type: COMPARATOR
Intervention: Finerenone 10 mg or 20 mg alone
Number of subjects: 807
Study 35701056 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-wide mass drug administration (cMDA)
Number of subjects: 48
Study 35701182 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib
Number of subjects: 0
Study 35701182 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib, M1, M2
Number of subjects: 0
Study 35701185 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 270
Study 35701296 — intervention group
Group type: EXPERIMENTAL
Intervention: Omentectomy
Number of subjects: 54
Study 35701384 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab
Number of subjects: 12
Study 35701489 — intervention group
Group type: EXPERIMENTAL
Intervention: Resting-state functional connectivity
Number of subjects: 19
Study 35701489 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-brain connectivity at the voxel level
Number of subjects: 19
Study 35701489 — intervention group
Group type: EXPERIMENTAL
Intervention: Relationship between connectivity and network selectivity
Number of subjects: 19
Study 35701541 — intervention group
Group type: EXPERIMENTAL
Intervention: RBD-based SARS-CoV-2 mRNA vaccine, specific dosage and duration not available
Number of subjects: 0
Study 35701673 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes
Number of subjects: 2210
Study 35702098 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary HBD-2 and LL-37 expression levels in T2DM patients with moderate to severe CP and poor blood sugar control
Number of subjects: 89
Study 35702098 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary HBD-2 and LL-37 levels
Number of subjects: 89
Study 35702687 — intervention group
Group type: EXPERIMENTAL
Intervention: EpiSmart (epithelium-on)
Number of subjects: 101
Study 35702830 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM-5 POUD
Number of subjects: 606
Study 35702830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-adjusted POUD
Number of subjects: 606
Study 35702830 — intervention group
Group type: EXPERIMENTAL
Intervention: Validators for POUD measures
Number of subjects: 606
Study 35702830 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-adjusted binary POUD
Number of subjects: 606
Study 35703113 — intervention group
Group type: EXPERIMENTAL
Intervention: sasanlimab (immune checkpoint inhibitor) combined with stereotactic body radiation therapy (SBRT)
Number of subjects: 0
Study 35703113 — intervention group
Group type: COMPARATOR
Intervention: sasanlimab (immune checkpoint inhibitor)
Number of subjects: 0
Study 35703267 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoquatrane (0.1 mmol Gd/kg body weight)
Number of subjects: 1
Study 35703267 — intervention group
Group type: EXPERIMENTAL
Intervention: Gadoquatrane
Number of subjects: 1
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Multicomponent relaxation interventions (behavioral interventions)
Number of subjects: 528
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Massage
Number of subjects: 528
Study 35703367 — intervention group
Group type: EXPERIMENTAL
Intervention: Touch therapy
Number of subjects: 528
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Multicomponent relaxation intervention
Number of subjects: 528
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Bedtime story
Number of subjects: 528
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Enhanced physical activity intervention
Number of subjects: 528
Study 35703367 — intervention group
Group type: COMPARATOR
Intervention: Play
Number of subjects: 528
Study 35703880 — intervention group
Group type: EXPERIMENTAL
Intervention: 11C-Metomidate PET-CT
Number of subjects: 25
Study 35703880 — intervention group
Group type: COMPARATOR
Intervention: Adrenal vein sampling (AVS)
Number of subjects: 25
Study 35703880 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-surgical outcomes
Number of subjects: 25
Study 35704034 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive hormones (LH, FSH, inhibin B, AMH, E1, E2, SHBG) measured during minipuberty
Number of subjects: 98
Study 35704372 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined iTBS+yoga intervention
Number of subjects: 20
Study 35704372 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS+yoga intervention
Number of subjects: 20
Study 35704787 — intervention group
Group type: EXPERIMENTAL
Intervention: Venetoclax and CLAD/LDAC alternating with venetoclax and 5-AZA
Number of subjects: 60
Study 35704795 — intervention group
Group type: EXPERIMENTAL
Intervention: T-cell-dependent vaccine against Haemophilus influenzae type b (Hib)
Number of subjects: 56
Study 35704795 — intervention group
Group type: EXPERIMENTAL
Intervention: T-cell-independent pneumococcal polysaccharide vaccine (PPSV)
Number of subjects: 56
Study 35704795 — intervention group
Group type: EXPERIMENTAL
Intervention: Hib vaccination responders
Number of subjects: 56
Study 35704976 — intervention group
Group type: COMPARATOR
Intervention: Fully vaccinated
Number of subjects: 2090
Study 35705312 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 106
Study 35705345 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic interventions (maxillary expansion, mandibular advancement, or maxillary complex advancement with skeletal anchored headgear)
Number of subjects: 70
Study 35705345 — intervention group
Group type: COMPARATOR
Intervention: Control (orthodontic intervention declined)
Number of subjects: 70
Study 35705345 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthodontic interventions
Number of subjects: 70
Study 35705362 — intervention group
Group type: EXPERIMENTAL
Intervention: Highest income quintile (≥€54,000)
Number of subjects: 203154
Study 35705362 — intervention group
Group type: COMPARATOR
Intervention: Lowest income quintile (≤€12,000)
Number of subjects: 203154
Study 35705788 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing intrauterine system (LNG-IUS) 52 mg
Number of subjects: 593
Study 35705844 — intervention group
Group type: EXPERIMENTAL
Intervention: Years living in the US
Number of subjects: 328
Study 35705844 — intervention group
Group type: EXPERIMENTAL
Intervention: English speaking proficiency
Number of subjects: 328
Study 35706068 — intervention group
Group type: EXPERIMENTAL
Intervention: Entre Nosotras + stress management intervention
Number of subjects: 220
Study 35706068 — intervention group
Group type: COMPARATOR
Intervention: Entre Nosotras alone
Number of subjects: 220
Study 35706358 — intervention group
Group type: EXPERIMENTAL
Intervention: Model averaging algorithm
Number of subjects: 54
Study 35706358 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum a posteriori prediction
Number of subjects: 54
Study 35706358 — intervention group
Group type: EXPERIMENTAL
Intervention: Model averaging using four models
Number of subjects: 54
Study 35706358 — intervention group
Group type: COMPARATOR
Intervention: Single-model approach
Number of subjects: 54
Study 35706483 — intervention group
Group type: EXPERIMENTAL
Intervention: Random Forest (RF) machine learning model
Number of subjects: 1117
Study 35706483 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression prediction model
Number of subjects: 1117
Study 35706483 — intervention group
Group type: EXPERIMENTAL
Intervention: RF model validated with additional 117 patients
Number of subjects: 1117
Study 35706483 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression model validated with additional 117 patients
Number of subjects: 1117
Study 35706792 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative VTE prevention measures
Number of subjects: 1217
Study 35707634 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption (drinkers)
Number of subjects: 907
Study 35707634 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent drinkers
Number of subjects: 907
Study 35707634 — intervention group
Group type: COMPARATOR
Intervention: Non-drinkers
Number of subjects: 907
Study 35707705 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-channel EEG features (A0)
Number of subjects: 82
Study 35707705 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-channel EEG features (ST4)
Number of subjects: 82
Study 35707705 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG features (Theta, Delta, A0, VC9)
Number of subjects: 82
Study 35707705 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG feature (VC9)
Number of subjects: 82
Study 35707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews with parents of children with cancer
Number of subjects: 23
Study 35707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of positive attitudes toward the children's cancer
Number of subjects: 23
Study 35707743 — intervention group
Group type: EXPERIMENTAL
Intervention: Low level of confidence
Number of subjects: 23
Study 35707873 — intervention group
Group type: EXPERIMENTAL
Intervention: Tezepelumab 210 mg SC Q4W
Number of subjects: 65
Study 35708131 — intervention group
Group type: EXPERIMENTAL
Intervention: Camp Kidpower intervention (CC training)
Number of subjects: 44
Study 35708166 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-assisted cognitive behavioural therapy for psychosis (CBTp)
Number of subjects: 16
Study 35708466 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunarizine treatment for 3 months
Number of subjects: 72
Study 35708634 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol Drinks
Number of subjects: 0
Study 35708744 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of smartphone health apps
Number of subjects: 739
Study 35708744 — intervention group
Group type: EXPERIMENTAL
Intervention: Health apps related to wellness, prevention, and fitness
Number of subjects: 739
Study 35708744 — intervention group
Group type: EXPERIMENTAL
Intervention: Health apps related to medication, treatments, and follow-up care
Number of subjects: 739
Study 35708744 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with health app use
Number of subjects: 739
Study 35708763 — intervention group
Group type: EXPERIMENTAL
Intervention: Distribution of self-diagnosis and self-treatment kits after training by health mediators (facilitators).
Number of subjects: 4863
Study 35708763 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile data collection using Android tablets with ODK Collect.
Number of subjects: 4863
Study 35708763 — intervention group
Group type: EXPERIMENTAL
Intervention: Custom R package and dashboard web app for data management.
Number of subjects: 4863
Study 35708794 — intervention group
Group type: EXPERIMENTAL
Intervention: DPEG
Number of subjects: 47
Study 35708794 — intervention group
Group type: COMPARATOR
Intervention: IRG
Number of subjects: 47
Study 35709178 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis Cessation Program (CCP), 8-week program
Number of subjects: 102
Study 35709957 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive and adaptive behavior functions analysis
Number of subjects: 65
Study 35709957 — intervention group
Group type: EXPERIMENTAL
Intervention: Development quotients for cognition and adaptive behavior
Number of subjects: 65
Study 35709957 — intervention group
Group type: EXPERIMENTAL
Intervention: Volumetric MRI analysis of brain
Number of subjects: 65
Study 35709957 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparan sulfate (HS) and heparan sulfate nonreducing ends (HS-NRE) levels measurement
Number of subjects: 65
Study 35709957 — intervention group
Group type: EXPERIMENTAL
Intervention: Signs of hepatomegaly
Number of subjects: 65
Study 35710225 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Video Game activities
Number of subjects: 32
Study 35710225 — intervention group
Group type: COMPARATOR
Intervention: Sedentary behavior (watching television)
Number of subjects: 32
Study 35710250 — intervention group
Group type: EXPERIMENTAL
Intervention: Xpert-Ultra
Number of subjects: 1009
Study 35710265 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 35710326 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung ultrasound performed before surgery to evaluate residual pulmonary alterations (≥ 3 B-lines and pleural thickening)
Number of subjects: 103
Study 35710326 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary compliance determination during surgery
Number of subjects: 103
Study 35710326 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative pulmonary complications collected during hospital stay
Number of subjects: 103
Study 35710326 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of postoperative pulmonary complications
Number of subjects: 103
Study 35710334 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillometry
Number of subjects: 80
Study 35710334 — intervention group
Group type: EXPERIMENTAL
Intervention: Spirometry
Number of subjects: 80
Study 35710334 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes
Number of subjects: 80
Study 35710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in My Home (AiMH) intervention, consisting of five individual and three group sessions led by an occupational therapist.
Number of subjects: 29
Study 35710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in My Home (AiMH) intervention.
Number of subjects: 29
Study 35710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in My Home (AiMH) intervention satisfaction rated by participants and staff at T2.
Number of subjects: 29
Study 35710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in My Home (AiMH) intervention satisfaction.
Number of subjects: 29
Study 35710347 — intervention group
Group type: EXPERIMENTAL
Intervention: Active in My Home (AiMH) intervention satisfaction rated by staff and participants at T2.
Number of subjects: 29
Study 35710368 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline to FU1 (March-June 2020)
Number of subjects: 1877
Study 35710368 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline to FU2 (June-September 2020)
Number of subjects: 1877
Study 35710369 — intervention group
Group type: EXPERIMENTAL
Intervention: T2D
Number of subjects: 0
Study 35710369 — intervention group
Group type: COMPARATOR
Intervention: EU
Number of subjects: 0
Study 35710369 — intervention group
Group type: COMPARATOR
Intervention: IR
Number of subjects: 0
Study 35710520 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Video
Number of subjects: 0
Study 35710520 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote Video plus Coaching
Number of subjects: 0
Study 35710578 — intervention group
Group type: EXPERIMENTAL
Intervention: Andexanet alfa
Number of subjects: 202
Study 35710578 — intervention group
Group type: COMPARATOR
Intervention: 4F-PCC
Number of subjects: 202
Study 35710733 — intervention group
Group type: EXPERIMENTAL
Intervention: Total metabolic tumor volume (TMTV)
Number of subjects: 0
Study 35710733 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor dissemination (Dmax)
Number of subjects: 0
Study 35710741 — intervention group
Group type: EXPERIMENTAL
Intervention: Bempegaldesleukin in combination with nivolumab
Number of subjects: 84
Study 35710944 — intervention group
Group type: EXPERIMENTAL
Intervention: International Weight Control Registry (IWCR)
Number of subjects: 0
Study 35710944 — intervention group
Group type: EXPERIMENTAL
Intervention: Data collection methods including questionnaires and objective measures
Number of subjects: 0
Study 35710944 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative information from participants
Number of subjects: 0
Study 35710944 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental data from public sources
Number of subjects: 0
Study 35711259 — intervention group
Group type: EXPERIMENTAL
Intervention: Pipeline Embolization Device (PED) therapy
Number of subjects: 652
Study 35711298 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory-reframing intervention
Number of subjects: 17
Study 35711298 — intervention group
Group type: COMPARATOR
Intervention: Control (normal reminiscing)
Number of subjects: 17
Study 35711355 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed mitral valve models
Number of subjects: 6
Study 35711382 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 2070
Study 35711382 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 2070
Study 35711561 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid-based formula
Number of subjects: 190